Abstract
Metabolic syndrome as a clustering of risk factors for diabetes and cardiovascular disease affects both men and women, but with important gender differences. Animal models have been used to understand disease progression and define therapeutic options, but most pre-clinical research on metabolic syndrome is undertaken in males. This opinion piece discusses the differences in male and female physiology that may influence both the development and the responses to pharmacological interventions of metabolic disorders, especially obesity. An appreciation of gender differences should improve the design and usefulness of biomedical experimental research to allow the development of relevant genderbased treatment options for chronic diseases including obesity, metabolic and cardiovascular diseases.
Keywords: Female bias, metabolic syndrome, inflammation, cardiovascular disease, reproduction, rat reproductive biology, socioeconomic, uterine, breast cancers, rheumatoid arthritis, multiple sclerosis, systemic lupus, autism, schizophrenia, asthma
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Gender Differences in Metabolic Syndrome – A Key Research Issue
Volume: 11 Issue: 3
Author(s): Abishek Iyer, Kathleen Kauter and Lindsay Brown
Affiliation:
Keywords: Female bias, metabolic syndrome, inflammation, cardiovascular disease, reproduction, rat reproductive biology, socioeconomic, uterine, breast cancers, rheumatoid arthritis, multiple sclerosis, systemic lupus, autism, schizophrenia, asthma
Abstract: Metabolic syndrome as a clustering of risk factors for diabetes and cardiovascular disease affects both men and women, but with important gender differences. Animal models have been used to understand disease progression and define therapeutic options, but most pre-clinical research on metabolic syndrome is undertaken in males. This opinion piece discusses the differences in male and female physiology that may influence both the development and the responses to pharmacological interventions of metabolic disorders, especially obesity. An appreciation of gender differences should improve the design and usefulness of biomedical experimental research to allow the development of relevant genderbased treatment options for chronic diseases including obesity, metabolic and cardiovascular diseases.
Export Options
About this article
Cite this article as:
Iyer Abishek, Kauter Kathleen and Brown Lindsay, Gender Differences in Metabolic Syndrome – A Key Research Issue, Endocrine, Metabolic & Immune Disorders - Drug Targets 2011; 11 (3) . https://dx.doi.org/10.2174/187153011796429808
DOI https://dx.doi.org/10.2174/187153011796429808 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure
Current Topics in Medicinal Chemistry Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents
Current Computer-Aided Drug Design Diuretic-Associated Electrolyte Disorders in the Elderly: Risk Factors, Impact, Management and Prevention
Current Drug Safety What’s Old is New Again – A Review of the Current Evidence of Colchicine in Cardiovascular Medicine
Current Cardiology Reviews Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells
Current Pharmaceutical Design The State of the Art in Anti-Malarial Drug Discovery and Development
Current Topics in Medicinal Chemistry Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets Editorial [Hot Topic:Translating Clinical Evidence into the Practice of Diabetes Care (Guest Editor: Richard W. Grant Contents)]
Current Diabetes Reviews Combinatorial Library Synthesis of Antioxidant Compounds
Combinatorial Chemistry & High Throughput Screening Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome
Current Molecular Medicine Immune-Mediated Mechanisms in Atherosclerosis: Prevention and Treatment of Clinical Manifestations
Current Pharmaceutical Design Averrhoa bilimbi L. leaf Aqueous Extract Modulates both Cardiac Contractility and Frequency in the Guinea-pig Atrium by the Activation of Muscarinic Receptors
Letters in Drug Design & Discovery Super-Resolution Based Enhancement of Cardiac MR Images
Current Medical Imaging Zebrafish as a Model System to Screen Radiation Modifiers
Current Genomics Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways
Current Drug Targets - Cardiovascular & Hematological Disorders Proteomic and Bioinformatic Analysis of Trypanosoma cruzi Chemotherapy and Potential Drug Targets: New Pieces for an Old Puzzle
Current Drug Targets